P-347 - The risk of hepatitis B virus (HBV) reactivation in patients with gastrointestinal stromal tumours (GIST) under imatinib mesylate treatment
| Autor: | Soufleris, K., Lazaraki, G., Pavlioglou, P., Stergiou, E., Paraskevaidou, K., Tzilves, D. |
|---|---|
| Zdroj: | In Annals of Oncology July 2019 30 Supplement 4:iv96-iv96 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|